Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jan 28;18(1):46.
doi: 10.1186/s13063-016-1768-4.

Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial

Enoch Akowuah  1 , Andrew T Goodwin  1 , W Andrew Owens  1 , Helen C Hancock  2 , Rebecca Maier  3 , Adetayo Kasim  3 , Adrian Mellor  1 , Khalid Khan  1 , Gavin Murphy  4 , James Mason  5
Affiliations
Randomized Controlled Trial

Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trial

Enoch Akowuah et al. Trials. .

Abstract

Background: Aortic valve replacement is one of the most common cardiac surgical procedures performed worldwide. Conventional aortic valve replacement surgery is performed via a median sternotomy; the sternum is divided completely from the sternal notch to the xiphisternum. Minimally invasive aortic valve replacement, using a new technique called manubrium-limited ministernotomy, divides only the manubrium from the sternal notch to 1 cm below the manubrio-sternal junction. More than one third of patients undergoing conventional sternotomy develop clinically significant bleeding requiring post-operative red blood cell transfusion. Case series data suggest a potentially clinically significant difference in red blood cell transfusion requirements between the two techniques. Given the implications for National Health Service resources and patient outcomes, a definitive trial is needed.

Methods/design: This is a single-centre, single-blind, randomised controlled trial comparing aortic valve replacement surgery using manubrium-limited ministernotomy (intervention) and conventional median sternotomy (usual care). Two hundred and seventy patients will be randomised in a 1:1 ratio between the intervention and control arms, stratified by baseline logistic EuroSCORE and haemoglobin value. Patients will be followed for 12 weeks from discharge following their index operation. The primary outcome is the proportion of patients who receive a red blood cell transfusion post-operatively within 7 days of surgery. Secondary outcomes include red blood cell and blood product transfusions, blood loss, re-operation rates, sternal wound pain, quality of life, markers of inflammatory response, hospital discharge, health care utilisation, cost and cost effectiveness and adverse events.

Discussion: This is the first trial to examine aortic valve replacement via manubrium-limited ministernotomy versus conventional sternotomy when comparing red blood cell transfusion rates following surgery. Surgical trials present significant challenges; strengths of this trial include a rigorous research design, standardised surgery performed by experienced consultant cardiothoracic surgeons, an agreed anaesthetic regimen, patient blinding and consultant-led patient recruitment. The MAVRIC trial will demonstrate that complex surgical trials can be delivered to exemplary standards and provide the community with the knowledge required to inform future care for patients requiring aortic valve replacement surgery.

Trial registration: International Standard Randomised Controlled Trial Number (ISRCTN) ISRCTN29567910 . Registered on 3 February 2014.

Keywords: Aortic valve replacement (AVR); Inflammatory response; Manubrium-limited ministernotomy; Minimally invasive aortic valve replacement; Red blood cell transfusion; Sternotomy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schedule of enrolment, intervention and assessments for the MAVRIC trial
Fig. 2
Fig. 2
Division and transection of the sternum in a manubrium-limited ministernotomy
Fig. 3
Fig. 3
Flow chart of the patient pathway for the MAVRIC trial
See this image and copyright information in PMC

References

    1. O’Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg. 2009;88(1 Suppl):S23–42. doi: 10.1016/j.athoracsur.2009.05.056. - DOI - PubMed
    1. The society of cardiothoracic surgery of Great Britain and Ireland. 5th National Adult Cardiac Surgical Database. 2003. www.scts.org/_userfiles/resources/5thBlueBook2003.pdf. Accessed 11 Mar 2016.
    1. Dunning J, Gao H, Chambers J, Moat N, Murphy G, Pagano D, Ray S, Roxburgh J, Bridgewater B. Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use — an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National Database. J Thorac Cardiovasc Surg. 2011;142(4):776–82. doi: 10.1016/j.jtcvs.2011.04.048. - DOI - PubMed
    1. Karkouti K. Transfusion and risk of acute kidney injury in cardiac surgery. Br J Anaesth. 2012;109(Suppl 1):i29–38. doi: 10.1093/bja/aes422. - DOI - PubMed
    1. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544–52. doi: 10.1161/CIRCULATIONAHA.107.698977. - DOI - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources